For the best experience of St Vincent Institute website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.    

Defects in the thymic microenvironment as the cause of T-cell acute lymphoblastic leukaemia

Lab: RNA & T Cell Biology

Supervisor(s): Associate Professor Mark Chong

Diseases focus: Cancer

Dr Rohan Bythell-Douglas

Diseases focus: Cancer
Masters/Honours

Unraveling Tumor Suppression with a Novel Breast Cancer Mouse Model

Lab: DNA Repair & Recombination

Supervisor(s): Associate Professor Wayne Crismani

Diseases focus: Cancer

Ruofei Liu

Diseases focus: Cancer
Honours/Masters

Roles of retinoic acid receptors in the regulation of haematopoietic stem cells

Lab: Stem Cell Regulation

Supervisor(s): Professor Louise Purton Dr Gavin Tjin

Diseases focus: Cancer

DNA Repair & Recombination

Diseases focus: Cancer

Dr Luban Sobah

Diseases focus: Cancer

Stem Cell Regulation

Diseases focus: Cancer

Dr Andrew Tsatsanis

Diseases focus: Cancer Healthy Ageing

DNA Damage & Cancer Therapy

Diseases focus: Cancer

Dr Caitlin Harris

Diseases focus: Cancer
PhD/Honours

Cancer mutation processes driven by stability of DNA:RNA hybrids

Lab: Genome Stability

Supervisor(s): Associate Professor Andrew Deans

Diseases focus: Cancer
Targeting the nucleoli to treat cancer

Targeting the nucleoli to treat cancer

Lab: DNA Damage & Cancer Therapy

Supervisor(s): Associate Professor Elaine Sanij Dr Jian Kang

Diseases focus: Cancer

Dr Abdulsalam Isiaku

Diseases focus: Cancer
PhD/Honours

Application of gene editing to the study of inherited breast and ovarian cancer

Lab: Genome Stability

Supervisor(s): Associate Professor Andrew Deans Associate Professor Wayne Crismani

Diseases focus: Cancer
Define the role of mRNA translation reprogramming in multiple myeloma progression and response to therapy

Define the role of mRNA translation reprogramming in multiple myeloma progression and response to therapy

Lab: DNA Damage & Cancer Therapy

Supervisor(s): Associate Professor Elaine Sanij Dr Jian Kang

Diseases focus: Cancer

Associate Professor Andrew Deans

Diseases focus: Cancer
PhD/Masters/Honours

mTORC1-AMPK signalling

Lab: Metabolic Signalling

Supervisor(s): Associate Professor Jon Oakhill Dr Naomi Ling

Diseases focus: Cancer
Engineering Immune Proteins to Enhance NK and T Cell Function for Tumour Therapy

Engineering Immune Proteins to Enhance NK and T Cell Function for Tumour Therapy

Lab: Structural Immunobiology

Supervisor(s): Dr Julian Vivian

Diseases focus: Cancer

Genome Stability

Diseases focus: Cancer